Pharmaceutical Products (General Anti-infectives for Systemic Use, Vaccines, Antineoplastics and Immunomodulators)

This tender, initiated by the Kyiv City Children's Clinical Hospital No. 1 (KNP "Kyivska miska dytacha klinichna likarnia №1"), is for the procurement of essential pharmaceutical products. The specific categories of medicines required are general anti-infectives for systemic use, vaccines, antineoplastics, and immunomodulators. The tender details include specific drug requirements such as Cefotaxime powder for injection (1g), Ceftazidime powder for injection (1.0g), and Cefazolin powder for injection (1g). These are all antibiotics commonly used to treat severe bacterial infections, particularly in hospital settings. The CPV code associated with this procurement is 33650000-1, which covers antibiotics for systemic use. The Kyiv City Children's Clinical Hospital No. 1, as the procuring entity, requires these medications to provide critical care to pediatric patients. The tender aims to ensure a stable and timely supply of these vital medicines to meet the hospital's treatment needs, supporting its capacity to manage infections, prevent diseases through vaccination, and treat conditions requiring antineoplastic and immunomodulatory therapies. The procurement is essential for maintaining the hospital's operational capacity and delivering high-quality healthcare services to children in Kyiv.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals, Pharmaceuticals and Vaccines. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 651,117.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.